Literature DB >> 1616807

Worldwide expansion of transnational tobacco industry.

G N Connolly1.   

Abstract

As smoking rates fall in North America and western Europe, transnational tobacco companies (TTCs) from the United States and Great Britain turn to cigarette markets of the developing world to replace those smokers who have quit or died from smoking. The majority of these markets are dominated by state tobacco monopolies that advertise and promote smoking minimally. Few women or adolescents smoke in those nations. The majority of men do, but they smoke far fewer cigarettes per year than their counterparts in developed nations. Trade barriers in the developing world prevent foreign cigarette companies from entering. TTCs employ various techniques to force open those markets, including trade pressure from the US government. Once the market is open, Western cigarette advertising and promotions target nonsmoking women and children. Retail tobacco outlets increase, smoking rates rise, and more death and disease result. Latin America was the TTC target in the 1960s, the newly developed nations of Asia during the 1980s, and, today, the tobacco giants are pushing into eastern Europe, China, and Africa. If nothing is done, emerging national smoking-control programs will be overwhelmed, and state-owned cigarette monopolies will be taken over by the TTCs. Policies and programs to curb smoking exist, but for various reasons many lesser developed countries have not adopted them. The threat of TTC entry into a closed market offers an opportunity to form national coalitions against smoking, educate the public about the dangers of tobacco use, and implement public health policies and programs to restrict marketing and use of cigarettes.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1616807

Source DB:  PubMed          Journal:  J Natl Cancer Inst Monogr        ISSN: 1052-6773


  21 in total

Review 1.  The economics of tobacco: myths and realities.

Authors:  K E Warner
Journal:  Tob Control       Date:  2000-03       Impact factor: 7.552

2.  Effects of market liberalisation on smoking in Japan.

Authors:  K Honjo; I Kawachi
Journal:  Tob Control       Date:  2000-06       Impact factor: 7.552

3.  Mentholated cigarettes and smoking cessation: findings from COMMIT. Community Intervention Trial for Smoking Cessation.

Authors:  A Hyland; S Garten; G A Giovino; K M Cummings
Journal:  Tob Control       Date:  2002-06       Impact factor: 7.552

4.  Tobacco control in Nepal during a time of government turmoil (1960-2006).

Authors:  Dharma Bhatta; Eric Crosbie; Stella Bialous; Stanton Glantz
Journal:  Tob Control       Date:  2019-07-30       Impact factor: 7.552

5.  Perception of foreign cigarettes and their advertising in China: a study of college students from 12 universities.

Authors:  S H Zhu; D Li; B Feng; T Zhu; C M Anderson
Journal:  Tob Control       Date:  1998       Impact factor: 7.552

6.  Understanding the vector in order to plan effective tobacco control policies: an analysis of contemporary tobacco industry materials.

Authors:  Anna B Gilmore
Journal:  Tob Control       Date:  2012-03       Impact factor: 7.552

7.  Are transnational tobacco companies' market access strategies linked to economic development models? A case study of South Korea.

Authors:  Sungkyu Lee; Chris Holden; Kelley Lee
Journal:  Glob Public Health       Date:  2013-01-18

Review 8.  Cancer burden and trends in the Asian Pacific Rim region.

Authors:  Binh H Yang; D Maxwell Parkin; Lin Cai; Zuo Feng Zhang
Journal:  Asian Pac J Cancer Prev       Date:  2004 Apr-Jun

9.  'A question of balance': addressing the public health impacts of multinational enterprises in the OECD Guidelines for Multinational Enterprises.

Authors:  Joshua S Yang; Patricia A McDaniel; Ruth E Malone
Journal:  Glob Public Health       Date:  2012-10-09

10.  Smoking in Ghana: a review of tobacco industry activity.

Authors:  E Owusu-Dabo; S Lewis; A McNeill; S Anderson; A Gilmore; J Britton
Journal:  Tob Control       Date:  2009-04-08       Impact factor: 7.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.